Internal Reference Number: FOI_6653
Date Request Received: 27/06/2022 00:00:00
Date Request Replied To: 27/07/2022 00:00:00
This response was sent via: By Email
Request Summary: Antifungal treatment
Request Category: Private Individuals
| Question Number 1: please answer the following questions concerning antifungal treatment within your organisation What is the number of patients in the last 12 months treated with the following product lines: A) anidulafungin B) caspofungin C) micafungin | |
| Answer To Question 1: Anidulafungin <5 Caspofungin 24 Micafungin 0 In addition 45 vials of caspofungin (of the total 104 in the period) were issued as stock to wards, the patient is not identifiable by pharmacy for these | |
| Question Number 2: What is the split of indication over the last 12 months for the following product lines: A) anidulafungin B) caspofungin C) micafungin | |
| Answer To Question 2: Information not held by the Trust | |
| Question Number 3: For each of the indication splits of the 3 product lines mentioned previously (anidulafungin, caspofungin and micafungin from Q2) list the average length of treatment time. | |
| Answer To Question 3: Information not held by the Trust | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of 看片软件 Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
